141 related articles for article (PubMed ID: 19524355)
1. Editorial comment on: detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
Dalbagni G
Eur Urol; 2010 May; 57(5):849. PubMed ID: 19524355
[No Abstract] [Full Text] [Related]
2. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
Mariappan P; Zachou A; Grigor KM;
Eur Urol; 2010 May; 57(5):843-9. PubMed ID: 19524354
[TBL] [Abstract][Full Text] [Related]
3. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
4. Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.
Shoshany O; Mano R; Margel D; Baniel J; Yossepowitch O
Urol Oncol; 2014 Jan; 32(1):40.e17-22. PubMed ID: 23911682
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Herr HW
Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043
[No Abstract] [Full Text] [Related]
6. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Witjes JA
Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044
[No Abstract] [Full Text] [Related]
7. Surgeon Scorecards Improve Muscle Sampling on Transurethral Resection of Bladder Tumor and Recurrence Outcomes in Patients with Nonmuscle Invasive Bladder Cancer.
Das A; Cohen JE; Ko OS; Jordan BJ; Glaser AP; Auffenberg GB; Meeks JJ
J Urol; 2021 Mar; 205(3):693-700. PubMed ID: 33021430
[TBL] [Abstract][Full Text] [Related]
8. Quality control in transurethral resection of bladder tumours.
Herr HW; Donat SM
BJU Int; 2008 Nov; 102(9 Pt B):1242-6. PubMed ID: 19035888
[No Abstract] [Full Text] [Related]
9. Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumour.
De La Peña E; Hernández V; Blázquez C; Martin MD; Díaz FJ; Capitán C; Alemany I; Llorente C
BJU Int; 2013 Apr; 111(4 Pt B):E196-201. PubMed ID: 23106771
[TBL] [Abstract][Full Text] [Related]
10. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
[TBL] [Abstract][Full Text] [Related]
11. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.
Rouprêt M; Yates DR; Varinot J; Phé V; Chartier-Kastler E; Bitker MO; Compérat E
Can J Urol; 2012 Oct; 19(5):6459-64. PubMed ID: 23040628
[TBL] [Abstract][Full Text] [Related]
12. Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.
Jaidane M; Bouicha T; Slama A; Hmida W; Hidoussi A; Ben Sorba N; Mosbah F
Urology; 2010 Jun; 75(6):1392-5. PubMed ID: 19781747
[TBL] [Abstract][Full Text] [Related]
13. Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
Colombo R
Eur Urol; 2007 Sep; 52(3):774-5. PubMed ID: 17434255
[No Abstract] [Full Text] [Related]
14. Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
Brausi M
Eur Urol; 2007 Sep; 52(3):775-6. PubMed ID: 17434253
[No Abstract] [Full Text] [Related]
15. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
17. Editorial comment.
Scarpa RM; Cracco CM
Urology; 2009 Dec; 74(6):1286-7; author reply 1287-8. PubMed ID: 19962530
[No Abstract] [Full Text] [Related]
18. A re-staging transurethral resection predicts early progression of superficial bladder cancer.
Herr HW; Donat SM
BJU Int; 2006 Jun; 97(6):1194-8. PubMed ID: 16566813
[TBL] [Abstract][Full Text] [Related]
19. The value of a second transurethral resection for T1 bladder cancer.
Schwaibold HE; Sivalingam S; May F; Hartung R
BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
